Find a Commonwealth Resource
Lazertinib
HealthData.Gov
Updated Jul 6, 2026
About this dataset
Lazcluze (lazertinib) is an oral prescription tablet medication classified as a kinase inhibitor. It is available in 80mg and 240mg strengths and is manufactured by Janssen Biotech, Inc. for treating specific conditions like certain cancers. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Lazertinib
Access the FDA dataset for Lazertinib — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025